Hormel Foods Corporation HRL

Hormel Foods Corporation se dedica a la producción de una variedad de productos cárnicos y alimenticios. La empresa opera a través de cuatro segmentos: Productos de supermercado, que se dedica al procesamiento, comercialización y venta de productos alimenticios de larga duración vendidos para el mercado minorista y también incluye productos de nutrición, como los productos de proteínas Muscle Milk; Alimentos refrigerados, que consiste en el procesamiento, comercialización y venta de productos de cerdo, res, pollo y pavo de marca y sin marca para clientes minoristas, de servicios de alimentos y productos frescos; Jennie-O Turkey Store (JOTS), que consiste en el procesamiento, comercialización y venta de productos de pavo de marca y sin marca para clientes minoristas, de servicios de alimentos y productos frescos; e Internacional y Otros, que incluye Hormel Foods International Corporation, que fabrica, comercializa y vende los productos de la empresa a nivel internacional. Las marcas de la empresa también incluyen Planters, NUT-rition, Planters Cheez Balls y Corn Nuts.

Con 50 acciones de HRL (USD 1.004,75) habrías recibido USD 58,00 en dividendos en los últimos 12 meses.

HRL hizo una división de acciones (split) de 2:1 el 10 de febrero de 2016: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 1 oct

  Can Hormel Foods' Brakebush Deal Accelerate Foodservice Growth?

  Hormel Foods has agreed to acquire Brakebush Brothers, a leading value-added chicken company, for approximately $1.055 billion. The deal, expected to close in Q1 fiscal 2027, will expand Hormel's presence in value-added chicken and strengthen its Foodservice segment. Brakebush generated $1.2 billion in net sales over the past 12 months and brings established sales capabilities, customer relationships, and production scale. The acquisition is expected to support growth and unlock operational synergies, with accretion to adjusted earnings per share beginning in fiscal 2028.

  

• Zacks Investment Research 29 sept

  Hormel Foods Pricing Strategy: Can It Balance Value and Profitability?

  Hormel Foods executed two pricing rounds that contributed to a 1% decline in total dollar consumption in Q3, while adjusted operating margin improved 60 basis points to 9% and adjusted EPS rose 6% to 37 cents. The company is adapting its portfolio, messaging, pack formats and pricing to address consumers' growing emphasis on value. HRL carries a Zacks Rank #3 (Hold) with a forward P/E of 12.99.

  

• The Motley Fool 27 ago

  Why Hormel Foods Stock Swooned by 10% Today

  Hormel Foods stock plummeted 10% after the company missed revenue expectations ($2.96B vs. $3.05B consensus), cut full-year net sales guidance to $12.1-$12.2B from $12.2-$12.5B, and reported a 7% drop in sales volume. While the company beat earnings per share estimates ($0.37 vs. $0.35 consensus), investors were unforgiving due to weak consumer demand, lower commodity-based pricing, and the company's already-eroded stock performance.

  

• Zacks Investment Research 27 ago

  Hormel Foods Q3 Earnings Beat on Margin Expansion, Sales Miss

  Hormel Foods reported Q3 adjusted EPS of 37 cents, beating consensus estimates, but net sales fell 2.4% to $2.96B, missing expectations. The company expanded operating margins by 60 basis points despite volume declines across segments. Hormel lowered fiscal 2026 sales guidance to $12.1-$12.2B but raised EPS guidance to $1.45-$1.51, reflecting a Brazil divestiture and challenging external environment.

  

• Zacks Investment Research 27 ago

  Compared to Estimates, Hormel (HRL) Q3 Earnings: A Look at Key Metrics

  Hormel Foods reported $2.96 billion in revenue for Q3 2026, missing analyst expectations of $3.05 billion by 2.81%. While EPS of $0.37 slightly beat estimates of $0.36, the company faced headwinds across most segments with retail sales down 4.3% and international sales declining 4.7% year-over-year. The stock has underperformed the broader market, declining 8.1% over the past month.